HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Barassi Selected Research

Istaroxime

1/2022SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
8/2013Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition.
9/2008Modulation of sarcoplasmic reticulum function by PST2744 [istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride)] in a pressure-overload heart failure model.
1/2007Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Barassi Research Topics

Disease

4Heart Failure
01/2022 - 01/2007
2Hypertrophy
09/2008 - 08/2004
2Hypertension (High Blood Pressure)
08/2004 - 12/2002
1Diabetic Cardiomyopathies
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Cardiomegaly (Heart Hypertrophy)
08/2004
1Hyperglycemia
12/2002

Drug/Important Bio-Agent (IBA)

4IstaroximeIBA
01/2022 - 01/2007
2CalciumIBA
08/2013 - 01/2007
1Pharmaceutical PreparationsIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
01/2022
1phospholambanIBA
08/2013
1Calcium-Transporting ATPases (Ca2+ ATPase)IBA
01/2007
1Protein Isoforms (Isoforms)IBA
01/2007
1Ouabain (G Strophanthin)IBA
08/2004
1rostafuroxinIBA
12/2002
1AldosteroneIBA
12/2002
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
12/2002
1ReninIBA
12/2002
1Antihypertensive Agents (Antihypertensives)IBA
12/2002
1DiureticsIBA
12/2002
1adducinIBA
12/2002

Therapy/Procedure

2Therapeutics
08/2013 - 01/2007